# To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia

> **NCT00007774** · PHASE4 · COMPLETED · sponsor: **US Department of Veterans Affairs** · enrollment: 600 (estimated)

## Conditions studied

- Schizoaffective Disorder
- Schizophrenia

## Interventions

- **DRUG:** Haloperidol
- **DRUG:** Olanzapine

## Key facts

- **NCT ID:** NCT00007774
- **Lead sponsor:** US Department of Veterans Affairs
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-03
- **Primary completion:** 2001-06
- **Final completion:** —
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2009-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00007774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00007774, "To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00007774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*